CALT - First RSV shots groundbreaking gene therapy among 2024 drugs to watch
2024-01-14 12:00:24 ET
More on CRISPR, GSK, etc.
- Pfizer Is Part Of The 2024 Healthcare Sector Rally Cohort
- Impact Of Gene Therapies And Casgevy On Crispr AG And The Industry
- CRISPR Therapeutics AG (CRSP) 42nd Annual J.P. Morgan Healthcare Conference (Transcript)
- Rebranded Investor Movement Index gains in December, still ‘moderately low’
- Pfizer suggests shareholders reject mini-tender offer by TRC Capital Investment
For further details see:
First RSV shots, groundbreaking gene therapy among 2024 drugs to watch